Content about Specialty Pharmacy

August 1, 2010
Merck discloses Q2 earnings

Merck had global sales of $11.3 billion and profits of $752 million during second quarter...

August 1, 2010
Sagent's generic Imitrex receives regulatory approval

The Food and Drug Administration has approved a generic injected drug made by Sagent Pharmaceuticals...

July 22, 2010
NACDS urges FDA to move carefully in risk management rules for opioids

Note to the Food and Drug Administration from the chain pharmacy industry: when it comes...

July 21, 2010
BI: Extended-release Viramune XR works as well as predecessor

A once-daily formulation of an HIV drug made by Boehringer Ingelheim works as well as...

July 21, 2010
Tibotec unveils efficacy results for investigational HIV drug

An investigational treatment for HIV made by Johnson & Johnson subsidiary Tibotec Pharmaceuticals works as...

July 20, 2010
Decision Resources: Only half of payers support biosimilar substitution

Biosimilars may have cleared their biggest stretch of wilderness thanks to their inclusion in the...

July 20, 2010
FDA advisory committee recommends limiting use of Genentech breast cancer drug

A Food and Drug Administration advisory committee has voted to recommend limiting use of a...

July 20, 2010
Fera acquires rights to investigational otomycosis treatment

Fera Pharmaceuticals has acquired rights to an investigational drug for treating a rare fungal ear...

July 19, 2010
BioScrip inks cancer drug deal with Access

Specialty pharmacy provider BioScrip and drug maker Access Pharmaceuticals have signed a distribution agreement for...

July 19, 2010
PhRMA: 313 mental disorder treatments are in development

More than 300 medications for treating mental disorders are in development, according to a new...

July 18, 2010
Amgen gets priority review from FDA

The Food and Drug Administration has given priority review to an application from Amgen for...

July 18, 2010
FDA accepts NDA for Eisai's Banzel

Eisai's new drug application for a drug designed as an adjunctive treatment of seizures associated...

July 18, 2010
J&J: Nucynta produced fewer side effects than competitor in trial

A Johnson & Johnson pain drug produced fewer side effects in patients than oxycodone, according...

July 18, 2010
Kaletra-Isentress therapy for HIV patients as effective as standard treatments, drug makers say

A combination therapy comprising of drugs made by Abbott and Merck is as effective as...

July 15, 2010
Cardinal Health completes Healthcare Solutions Holding acquisition

Cardinal Health's specialty pharmaceutical services have expanded with the help of the now-completed Healthcare Solutions...

July 15, 2010
FDA advisory committee shoots down Vivus' Qnexa

The possibility of a new drug for treating obesity suffered a setback Thursday as a...

July 15, 2010
Millipore officially becomes part of Merck KGaA

German drug maker Merck KGaA has finished acquiring U.S. life-sciences company Millipore, Merck KGaA said...

July 14, 2010
Endo completes HealthTronics acquisition

Endo Pharmaceuticals has completed its acquisition of a company that provides urological products and services,...

July 14, 2010
Keryx gets orphan-drug designation for neuroblastoma treatment

The Food and Drug Administration has given special designation to an investigational treatment for a...

July 14, 2010
Mylan acquires Bioniche Pharma

Generic drug maker Mylan is hoping to gain entry into the injectable drug market with...

July 14, 2010
Watson inks deal with Itero

Watson Pharmaceuticals will work with a venture-backed firm to develop a biosimilar treatment for female...

July 13, 2010
Datamonitor: Oral drugs set to dominate MS market by 2014

The market for multiple sclerosis drugs, long dominated by biologics and injectables, soon could see...

July 13, 2010
Pfizer, Samsung Medical Center form liver cancer research partnership

Treatments for liver cancer could emerge from a new research partnership between the world’s largest...

July 12, 2010
Centric Health Resources head to address 5th Annual Rare Disease Leadership Summit

The 5th Annual Rare Disease Leadership Summit being held Wednesday in Arlington, Va., will feature...

July 12, 2010
Lonza to help manufacture Human Genome Sciences' Benlysta

A developer of a new drug for treating lupus has entered a supply agreement with...

© 2013 Drug Store News. All Rights Reserved.